Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives

Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives

Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It accounts for 15%–20% of all breast cancers and is associated with an aggressive evolution and poor outcomes with the maj...

Full description

Saved in:
Bibliographic Details
Main Authors: Karima Oualla, Loay Kassem, Lamiae Nouiakh, Lamiae Amaadour, Zineb Benbrahim, Samia Arifi, Nawfel Mellas
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2020/8209173
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items